Next Article in Journal
Deletion of Macrophage-Specific Glycogen Synthase Kinase (GSK)-3α Promotes Atherosclerotic Regression in Ldlr−/− Mice
Next Article in Special Issue
Cervicovaginal Microbiota Composition in Chlamydia trachomatis Infection: A Systematic Review and Meta-Analysis
Previous Article in Journal
In Vitro Bioactivity and Antibacterial Effects of a Silver-Containing Mesoporous Bioactive Glass Film on the Surface of Titanium Implants
Previous Article in Special Issue
Bortezomib Eliminates Persistent Chlamydia trachomatis Infection through Rapid and Specific Host Cell Apoptosis
 
 
Article
Peer-Review Record

Genetic Variation in the MBL2 Gene Is Associated with Chlamydia trachomatis Infection and Host Humoral Response to Chlamydia trachomatis Infection

Int. J. Mol. Sci. 2022, 23(16), 9292; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms23169292
by Stephan P. Verweij 1,*, Remco P. H. Peters 2,3, Arnold Catsburg 4, Henry J. C. de Vries 5,6,7,8, Sander Ouburg 9 and Servaas A. Morré 10
Reviewer 1: Anonymous
Reviewer 2:
Int. J. Mol. Sci. 2022, 23(16), 9292; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms23169292
Submission received: 8 July 2022 / Revised: 8 August 2022 / Accepted: 15 August 2022 / Published: 18 August 2022
(This article belongs to the Special Issue Chlamydia trachomatis Pathogenicity and Disease)

Round 1

Reviewer 1 Report

The manuscript Genetic variation in the MBL2 gene is associated with Chlamydia trachomatis infection and host humoral response to Chlamydia trachomatis infection has a sufficient number of samples included in the study. The methods are adequately described and used, results supported by the conclusions. It is stated by the authors that this is the only study of correlation between Chlamydia infection and MBL gene polymorphisms so I encourage the authors to include in the Introduction and Discussion some other variations in the immune system in general that can be correlated with Chlamydia infection. It would definitely improve the quality of the manuscript and help reduce the number of self-citations.

Author Response

The manuscript Genetic variation in the MBL2 gene is associated with Chlamydia trachomatis infection and host humoral response to Chlamydia trachomatis infection has a sufficient number of samples included in the study. The methods are adequately described and used, results supported by the conclusions. It is stated by the authors that this is the only study of correlation between Chlamydia infection and MBL gene polymorphisms so I encourage the authors to include in the Introduction and Discussion some other variations in the immune system in general that can be correlated with Chlamydia infection. It would definitely improve the quality of the manuscript and help reduce the number of self-citations.

 

We thank the reviewer for carefully reviewing our manuscript. Several different pathways have been described by us and other research groups concerning Chlamydia trachomatis infection. The MBL2 polymorphisms have, however, not been described yet in this context. We added additional information on associated SNPs within the discussion.

Author Response File: Author Response.docx

Reviewer 2 Report

The study conducted by the authors is interesting to the Chlamydia scientific community. This reviewer has few concerns:

1. What is the threshold Ct value for considering the samples Chlamydia positive?

2. Please elaborate section 2.3 of materials and method. 

Author Response

The study conducted by the authors is interesting to the Chlamydia scientific community. This reviewer has few concerns:

 

  1. What is the threshold Ct value for considering the samples Chlamydia positive?

 

  1. Please elaborate section 2.3 of materials and method.

 

 

We also thank this reviewer for carefully reviewing our manuscript.

  1. These clinical samples are deemed positive when Ct-values <40, this is the cut-off used in the Netherlands. We added the Ct cut-off within the materials and methods section.

 

  1. We added extra details within this section.

Author Response File: Author Response.docx

Back to TopTop